Study Might Lead to New AIDS Treatment
Posted on: Thursday, 3 July 2008, 15:00 CDT
U.S. scientists say they've used tiny proteins called zinc fingers to modify T-cell receptor genes in a study that may lead to a new type of AIDS treatment.
Researchers at the University of Pennsylvania School of Medicine and colleagues at Sangamo BioSciences Inc. of Richmond, Calif., said their goal is to use modified T cells from an HIV-infected person for that person's own treatment. They showed that, by using the zinc fingers, they could reduce the viral load of immune-deficient mice transplanted with engineered T cells.
The researchers, led by Dr. Elena Perez, an assistant professor of pediatrics, and Dr. Carl June, a professor of pathology and laboratory medicine at Penn, are planning a clinical trial in humans in which T cells from HIV patients would have their CCR5 gene -- necessary for the AIDS virus to enter immune system cells -- deliberately knocked out.
The modified T cells could then be infused back into the patients to re-establish their immune system and decrease their viral load.
The research is reported online in the journal Nature Biotechnology.
Source: United Press International
Related Articles
- Scientists Show White Blood Cells Move Like Millipedes
- Genetic Breakthrough Creates Immunity to Viruses
- T Cells Fighting Infection Get Exhausted
- Study Determines How Viruses Evade T-Cells
- Mid-Stage HIV Vaccine Trial Shows Encouraging Results
- Cell Immune Dampening Signal Identified
- Vical DNA Vaccine Elicits Lasting Memory T-Cell Immune Responses in Humans
- Promising Results for Vical's HIV Vaccine
- Broad T-Cell Immunity Against HIV Generated in Prime-Boost Vaccine Phase 1 Trial
- Group IB Secretory Phospholipase A2 Inhibits Human Dendritic Cell Immune Functions
 |
 |
User Comments (0)
RSS Feeds